MAIA

MAIA Biotechnology Inc.

AMEX: MAIA · HEALTHCARE · BIOTECHNOLOGY

$1.18

+1.72% today

Updated 2026-10-29

Market cap

$71.00M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.62

Dividend yield

—

52W range

$1 – $3

Volume

0.5M

Market cap

$71.00M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.62

Dividend yield

—

52W range

$1 – $3

Volume

0.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.8

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-22.8

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →271 stocks currently score above 75

Price targets

Analyst target

$12.00

+916.95%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -22.76 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-6.75M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-15.77M	$-19.77M	$-23.25M	$-22.40M	$-7.94M
EPS	—	—	—	—	$-0.62
Free cash flow	$-12.10M	$-13.07M	$-15.70M	$-18.84M	$-6.75M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MAIA	$71.00M	17	4.3	3.0	5.0	4.8	—	Avoid
LLY	$1.12T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$615.87B	57	4.7	8.5	2.7	5.5	-83.05%	Buy
ABBV	$504.37B	73	6.7	8.5	4.0	5.0	-86.73%	Strong Buy
UNH	$360.32B	62	6.7	6.0	4.7	5.5	-25.92%	Buy
MRK	$360.08B	36	4.0	4.5	2.0	5.0	-73.68%	Hold

Smart narrative

MAIA Biotechnology Inc. trades at $1.18. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -22.76, it sits in the distress.

Frequently asked questions

What is MAIA Biotechnology Inc.'s stock price?

MAIA Biotechnology Inc. (MAIA) trades at $1.18.

Is MAIA Biotechnology Inc. overvalued?

MAIA Biotechnology Inc. carries a Smart Value Score of 17/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of MAIA Biotechnology Inc. (MAIA)?

The 12-month analyst consensus target is $12.00, about 916.9% above the current $1.18. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

MAIA Biotechnology Inc.'s Altman Z-Score is -22.76, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeAMEX

CurrencyUSD

maiabiotech.com

Quick metrics

P/S ratio—

ROE-87.34%

Beta0.28

50D MA$1.27

200D MA$1.47

Shares out0.06B

Float0.06B

Short ratio—

Avg volume0.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

MAIA vs LLY →MAIA vs JNJ →MAIA vs ABBV →Stock screener →